<DOC>
	<DOCNO>NCT02188290</DOCNO>
	<brief_summary>Study CR-AIR-006 part ATIR clinical development plan provide control data patient treat ATIR clinical study ( e.g . study CR-AIR-007 ) .</brief_summary>
	<brief_title>Transplant-Related Mortality Patients Undergoing Peripheral Blood Stem Cell Transplantation Umbilical Cord Blood Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Any following hematologic malignancy : Acute myeloid leukemia ( AML ) remission time transplantation Acute lymphoblastic leukemia ( ALL ) remission time transplantation Myelodysplastic syndrome ( MDS ) Patient receive following transplantation : Allogeneic Tcell deplete HSCT without ATIR administration haploidentical donor 1 January 2006 30 June 2013 ( HAPLO group ) Allogeneic HSCT fully match 1locus mismatch unrelated donor 1 January 2010 31 December 2012 ( MUD/MMUD group ) Double umbilical cord blood transplantation 1 January 2010 31 December 2012 2 human leukocyte antigen ( HLA ) mismatch HLAA , B , and/or DR unit recipient ( UCB group ) Male female , age ≥ 18 , ≤ 65 year . Allogeneic stem cell transplantation prior transplantation qualify study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Haploidentical donor</keyword>
	<keyword>Unrelated donor</keyword>
	<keyword>Umbilical cord blood</keyword>
	<keyword>Graft versus host disease</keyword>
	<keyword>Transplant-related mortality</keyword>
	<keyword>Hematologic malignancy</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>